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Abstract
Myotonic dystrophy type 1 (DM1) is associated with one of the most highly unstable CTGNCAG repeat expansions. The
formation of further repeat expansions in transgenic mice carrying expanded CTGNCAG tracts requires the mismatch repair
(MMR) proteins MSH2 and MSH3, forming the MutSb complex. It has been proposed that binding of MutSb to CAG hairpins
blocks its ATPase activity compromising hairpin repair, thereby causing expansions. This would suggest that binding, but
not ATP hydrolysis, by MutSb is critical for trinucleotide expansions. However, it is unknown if the MSH2 ATPase activity is
dispensible for instability. To get insight into the mechanism by which MSH2 generates trinucleotide expansions, we
crossed DM1 transgenic mice carrying a highly unstable .(CTG)300 repeat tract with mice carrying the G674A mutation in
the MSH2 ATPase domain. This mutation impairs MSH2 ATPase activity and ablates base–base MMR, but does not affect the
ability of MSH2 (associated with MSH6) to bind DNA mismatches. We found that the ATPase domain mutation of MSH2
strongly affects the formation of CTG expansions and leads instead to transmitted contractions, similar to a Msh2-null or
Msh3-null deficiency. While a decrease in MSH2 protein level was observed in tissues from Msh2G674 mice, the dramatic
reduction of expansions suggests that the expansion-biased trinucleotide repeat instability requires a functional MSH2
ATPase domain and probably a functional MMR system.
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Introduction
Myotonic dystrophy type 1 (DM1) is a neuromuscular disease
characterized by highly variable clinical manifestations including
skeletal muscle, cardiorespiratory and brain defects and endocrine
abnormalities [1]. DM1 results from the expansion of an unstable
CTG trinucleotide repeat in the 39-untranslated region of the
dystrophia myotonica protein kinase (DMPK) gene [2–4]. In
normal individuals, the CTG repeat at the DM1 locus varies from
5 to 37 repeats and remains stable over generations. Tract lengths
of .50 CTG repeats are dramatically unstable in successive
generations, with a strong bias towards expansions, often reaching
thousands of CTGs in the most severe form of the disease [1]. The
level of CTG repeat instability depends on the sex and repeat
length of the transmitting parent [5,6]. The size of the expanded
repeat inversely correlates with the age at onset and is positively
correlated with the severity of symptoms providing the molecular
basis for anticipation [7]. In addition to intergenerational
instability, the CTG repeat is also somatically unstable in DM1
patients. Somatic instability, which is age-dependent, biased
towards expansions of CTG repeat length, presents variable
expansion patterns between tissues, and is probably associated
with the progression of disease symptoms in DM1 patients [8]. A
better understanding of the molecular mechanisms underlying
trinucleotide repeat instability is fundamental for the development
of therapies aimed at controlling trinucleotide repeat instability.
Such therapeutic approaches would hopefully reduce the disease
severity and progression of the symptoms.
Extensive analysis of repeat instability in various model systems
in vitro and in vivo has revealed crucial insights into the role of cis-
elements, DNA replication and genome-maintenance repair [9–
12]. Numerous transgenic mouse models and their derived cell
lines revealed that the repeat expansion rate does not always
correlate with cell division rate, suggesting the involvement of
various replication-independent mechanisms [13,14]. Studies have
reported that several mismatch repair (MMR) proteins are
involved in expansion-biased trinucleotide instability in transgenic
mouse models carrying expanded CTGNCAG repeat tracts.
Accumulation of CTGNCAG expansions in mitotic, non-mitotic
and germline tissues clearly depends on the MMR proteins
MSH2, MSH3 and to a lesser extent on PMS2 (postmeiotic
segregation homologue 2) [15–20]. Precisely how MutS homo-
logues MSH2 and MSH3 mediate CTGNCAG repeat expansions
has not yet been clearly determined.
MMR proteins are required to maintain genomic integrity in
prokaryotes and eukaryotes, by correcting single mismatches and
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short unpaired regions, such as small insertions and deletions
[21,22]. In eukaryotes, three proteins are involved in mismatch
recognition, MSH2, MSH3 and MSH6. The three proteins form
two heterodimers MutSa (MSH2-MSH6) and MutSb (MSH2-
MSH3). MutSa is thought to be involved primarily in the
recognition and repair of base-base mismatches and small
insertion/deletion loops. MutSb acts preferentially on insertion/
deletion loops up to 12 nucleotides in length [23]. MMR is tightly
linked with the mismatch-binding-dependent ATPase activities of
the MSH complexes but the precise roles of these activities are still
in debate. Upon binding to the mismatch, the MSH complex
exchanges a bound ADP for an ATP, which permits a change in
the proteins conformation and the signaling of downstream repair
events [21,22,24,25]. The MSH2, MSH3, and PMS2 mismatch
repair proteins are also involved in other DNA repair pathways
such as single-strand annealing and homologous recombination,
anti-recombination, DNA damage signaling, apoptosis, as well as
site-specific mutagenesis during immunoglobin somatic hypermu-
tation and class switch recombination [26–29]. While the MSH2
ATPase activity is known to be required for some of these non-
MMR functions, the specific roles of ATP-binding and ATP-
hydrolysis remain to be elucidated.
Different scenarios have been suggested to explain the role of
MMR proteins in trinucleotide repeat instability. It has been
shown that CTGNCAG repeat tracts can form hairpin structures
and/or slipped-strand structures in vitro [30,31]. These structures
are suspected to disturb DNA metabolism in vivo, leading to
trinucleotide repeat instability [9]. An initial study reported that in
vitro MSH2 can recognize and bind to slipped-strand (S-DNA)
structures formed by expanded CTGNCAG repeat tracts [32].
More recently, a detailed study of MutSb binding in vitro to long
CAG hairpin structures was reported [18], as well as an in vitro
assay to process slipped-DNAs [33].
Three models explaining the mechanism through which the
MMR proteins MSH2 and MSH3 act to generate CTGNCAG
expansions have been put forth. The first model proposes that the
role of the MMR proteins MSH2-MSH3 (MutSb) in trinucleotide
repeat expansions is through protecting CAG loops from repair by
binding the loops [18]. This model was based upon the reduced
ability of the human MutSb complex to hydrolyze ATP when
bound to hairpins formed by either (CAG)13 or (CTG)13;
suggesting that the protein complex would be stuck on the loop,
unable to translocate along the helix, and unable to signal or
interact with downstream repair proteins. In this manner binding
of MutSb to CAG or CTG hairpins would abort their repair,
thereby allowing the loops to be incorporated into the genome as
expansions. Thus, in this model MutSb binding but not ATP
hydrolysis would be critical for expansions.
The second model posits that the MutSb complex is not
required for CTG or CAG slip-out processing or protecting them
from repair, but rather MutSb may be involved in expansion prior
to the processing of the slip-outs [33]. An in vitro repair assay using
slipped-DNAs with slip-outs of either (CAG)20 or (CTG)20
revealed that these can be correctly repaired, escape repair, or
be repaired in an error-prone manner (only partially excising the
slip-outs). All of these processes occurred in human cell extracts
deficient in either MSH2 or MSH3. These authors suggested that
rather than acting in the processing or protecting CTG or CAG
slip-outs from repair, MutSb may be involved in forming the slip-
outs. It is unknown if such an activity would require the
endogenous ATPase activity of the protein.
The third model suggests that the mismatch repair process itself
is involved in trinucleotide repeat expansions [17]. This study
demonstrated that the MutL MMR homologue PMS2 is also
involved in CTGNCAG repeat somatic expansions in mice. Some
repeat expansions are still formed in PMS2-deficient mice
suggesting a partial role of PMS2 in trinucleotide repeat instability
[17]. The authors proposed that the MMR activity is required to
generate somatic expansions implying that the role of MMR
proteins would not be limited to the binding of MutSb complex to
the A-A mismatches in CAG hairpins and/or to the MutSb-
mediated formation of slipped-strand structures. In this model the
ATPase activity of the MutSb would be critical to expansions.
In an attempt to distinguish between the different hypotheses
and to clarify the role of the ATPase activity of MSH2 in the
mechanism of CTGNCAG expansion, we crossed Msh2 ATPase-
defective mice (Msh2G674A mice) with mice carrying a large
unstable CTG expansion (DM300-328) [27,34,35]. The DM300-
328 mice carrying.300 CTG repeats in the context of the human
genomic DM1 locus of over 45 kb display very high levels of
intergenerational and somatic instability similar to that observed in
DM1 patients [36]. The Msh2-mutant mice carry a missense
mutation of a glycine-to-alanine within the Walker ‘‘type A’’ motif
GXXXXGKS/T of the MSH2 ATPase domain [27,34] . This
ATPase domain in MSH2 and in many proteins with ATPase
function, is known to coordinate the phosphate groups of ATP
[34]. Mismatch binding experiments using Msh2G674A/G674A ES
cell extracts demonstrated that the mutant MSH2G674A-MSH6
complex retained normal mismatch binding activity. However, the
complex was resistant to ATP-mediated mismatch release and had
lost its capacity to signal mismatch repair resulting in MMR-
deficiency similar to that observed in Msh22/2 null mutant
extracts. Moreover, the homozygous ATPase mutation caused a
mutator phenotype, increased genome-wide mononucleotide and
dinucleotide instability in the genome of mutant mice similar to
that observed in Msh22/2 mice. However, in contrast to the Msh2-
null allele, the Msh2G674A mutation did not significantly affect the
cellular response to DNA damage-inducing agents, indicating that
normal ATP processing with subsequent repair is not essential for
the apoptosis signalling function of MSH2 [34]. Therefore,
Msh2G674A mutant mice appeared to be an excellent model to
determine if MSH2 ATPase activity is required for CTGNCAG
repeat expansions or if MSH2 binding to the trinucleotide repeats
Author Summary
Myotonic dystrophy type 1 is a neuromuscular disease
characterized by highly variable clinical manifestations,
including muscular and neuropsychological symptoms.
DM1 results from the dramatic expansion of an unstable
CTG repeat in the DMPK gene. Longer CTG repeats cause a
more severe form of the disease and an earlier age of
onset. The DNA mismatch repair proteins MSH2 and MSH3
are known to be major players in the formation of
trinucleotide expansions. Nevertheless, the mode of action
of these proteins remains elusive. In order to get further
insight into the role of MSH2 in the formation of CTG
expansions, we used a mouse model carrying a mutation
in the conserved ATPase domain of Msh2. This mutation
affects the function of this domain and alters the DNA
repair mismatch activity. After breeding of these mice with
mice carrying highly unstable CTG repeats, we found that
the ATPase domain mutation of MSH2 strongly affects the
formation of CTG expansions. Our findings show that
expansion-biased trinucleotide repeat instability requires a
functional MSH2 ATPase domain and support the hypoth-
esis, according to which a functional MMR activity is
required to generate expansions.
MSH2 ATPase Domain and Repeat Instability
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is sufficient to generate expansions in transgenic mice. We assessed
intergenerational repeat instability over successive generations and
somatic mosaicism in CTG repeat containing mice deficient for
MSH2 ATPase activity. The Msh2G674A/G674A mice showed a
dramatic decrease in CTG repeat expansions and an increase in
contractions; a pattern paralleling that observed in Msh22/2
transgenic mice. Our data indicate that the ATPase-defective
Msh2G674A mutation affects intergenerational and somatic insta-
bility of CTGNCAG repeats in transgenic mice.
Results
To assess the consequence of the G674A Msh2 missense
mutation in the generation of expanded trinucleotide repeats, we
crossed ATPase-defective Msh2 mutant mice [27,34] with
DM300-328 mice carrying the human DMPK gene with .300
CTG repeats, which show high levels of intergenerational and
somatic instability that is biased towards expansions and age-
dependent [36]. We analyzed the length of the CTG repeat
inherited from males and females, after weaning, in tail DNA from
mice with different Msh2 genotypes, as previously described [36].
The CTG instability in the various transmissions are reported in
Table 1 and Figure 1. In Msh2+/+ transgenic mice, we observed a
high level of intergenerational instability biased towards expan-
sions (100% and 62.3% expansions in offspring from male and
female transmissions, respectively). In the Msh2G674A/+ transmis-
sions, the frequency of expansions significantly decreased for both
male and female transmissions (from 100% to 75% and from
62.3% to 37.9%, respectively). For both paternal and maternal
Msh2G674A/G674A transmissions, the frequency of expansions
dramatically decreased (down to 12.1% and 0% in male and
female transmissions, respectively). At the same time, the
frequencies of CTG contractions increased in Msh2G674A/+ and
Msh2G674A/G674A transgenic mice. The distributions of the
magnitudes of intergenerational CTG repeat length changes were
significantly different between Msh2+/+ and Msh2G674A/+ and
between Msh2+/+ and Msh2G674A/G674A transmissions; p,0.005
and p,0.0001, respectively, both for male and female transmis-
sions (assessed by the Mann-Whitney test). Interestingly, much
larger contractions are observed in Msh2G674A/G674A female
transmissions (with a mean of 241.9 CTG units). The sizes of
contractions were positively correlated with the age of the
transmitting female (r2 = 0.718, p,0.0001).
In summary, these data support the idea that the G674A
mutation of one or both Msh2 alleles significantly decreased the
frequency of repeat expansions in paternal and maternal
transmissions, suggesting that a functional MSH2 ATPase domain
is required to generate expansions. Furthermore, these data
indicate that the ATPase-mutant MSH2 is sufficient to lead to a
preferential formation of CTG contractions that also arise in the
Msh2-null and Msh3-null DM1 mice [19,20]. Together these results
support a requirement of a functional MSH2 ATPase domain for
the expansion-biased parent to offspring CTG transmissions, and
that this defect is sufficient to cause the formation of transmitted
CTG contractions, which also arise in the absence of either MSH2
of MSH3 [19,20].
Both MSH2 and MSH3 proteins are required for CTG
expansions in somatic tissues [19,20,37], yet the requirement of
the MSH2 ATPase domain is unknown. Thus, we analysed the
somatic CTG instability in several tissues collected from 8-month-
old transgenic mice with different Msh2 genotypes. Wild-type mice
show inter- and intra-tissue CTG length mosaicism biased towards
expansions, pronounced in pancreas and germinal tissues, as
previously observed [19,36] (Figure 2 and data not shown for
female mice). A striking change in somatic instability was not
readily observed by standard PCR for the Msh2G674A/+ mice. In
contrast, expansions were clearly not detected in Msh2G674A/G674A
tissues and contractions were easily observed in testis and sperm,
but not in somatic tissues. Somatic instability was assessed with
greater sensitivity using small-pool PCR (SP-PCR). Tissues
assessed by SP-PCR include ovaries, testis, brain and cerebellum;
tissues known to display a range of instability levels in repair-
proficient mice. The inherited size in each mouse is represented by
the CTG repeat length in blood, liver or in tail at weaning, in
which somatic instability is minimal throughout the animal’s life
[19]. In Msh2G674A/+ mice, the degree of somatic mosaicism seems
to be unchanged in all tissues analysed, and where present showed
an expansion bias (Figure 3). In contrast, the degree of somatic
CTG mosaicism was strikingly decreased in all tissues tested from
the Msh2G674A/G674A mice. Neither expansions nor high levels of
contractions were evident by either standard PCR or SP-PCR for
the ATPase mutant mice, except in brain, where very small
expansions could be detected. The absence of expansions in
Msh2G674A/G674A mice parallels their loss in Msh22/2 mice.
However, the absence of contractions in somatic tissues of
Msh2G674A/G674A mice contrasts with their detection in tissues of
Msh22/2 mice [19]. These results show that the homozygous
Msh2G674A mutation reduces the formation of CTGNCAG
expansions in somatic tissues, while mutation of a single allele
has no significant effect. These results also indicate that the
Msh2G674A/G674A mutation does not lead to high levels of
Table 1. Intergenerational CTG repeat instability in transgenic mice carrying the G674A Msh2 mutation.
Parent to offspring
transmission
Transmissions
analysed (n)
Expansion
frequency (%)
Contraction
frequency (%)
Mean Expansion
length (CTG)n
Mean Contraction
length (CTG)n
Male transmissions
Msh2 +/+ to +/+ 41 100 0 +19.5
Msh2 m/+ to m/+ 24 75 16.7 +15.6 218.75
Msh2 m/m to m/m 33 12.1 78.8 +5 211.2
Female transmissions
Msh2 +/+ to +/+ 53 62.3 18.85 +10.8 28
Msh2 m/+ to m/+ 37 37.9 32.4 +7.1 210.8
Msh2 m/m to m/m 27 0 100 241.9
+/+/, m/+ and m/m represent specific genotype at the murine Msh2 locus. +: wild-type allele; m: G674A Msh2 mutation.
doi:10.1371/journal.pgen.1000482.t001
MSH2 ATPase Domain and Repeat Instability
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CTGNCAG contractions in somatic tissues, which contrasts with
their formation in tissues of Msh22/2 mice [19].
We have shown that CTG instability is dramatically decreased
in Msh2G674A/G674A, supporting the idea that the G674A mutation
in MSH2 ATPase domain affects CTG repeat instability. Lin et al.
demonstrated that this mutant ATPase domain alters the MMR
pathway in Msh2G674A/G674A mice without affecting the mismatch
binding activity [34]. The stability of MSH2, MSH6 and MSH3
proteins depends on the presence of each partner involved in the
formation of the MutSa and MutSb complexes [38,39]. In
embryonic fibroblasts from Msh2G674A/G674A mice, expression
levels of MSH2 and MSH6 proteins were normal, suggesting that
the ATPase mutation did not alter the stability of these proteins
[34]. We assessed the amount of MSH2 protein in germinal and
cerebral tissues from 3 to 4-month-old transgenic mice with
different Msh2 genotypes, by western blot. We observed a decrease
of MSH2 protein in Msh2G674A/G674A germinal tissues (to 13% in
ovaries, to 50% in testis, p,0.001, t-test), cerebellum (to 19%
p,0.001, t-test) and brain (to 62%, p=0.005, t-test) (Figure 4). In
mice heterozygous for the G674A mutation, MSH2 protein levels
were also decreased only in germinal tissues (to 37% and 80% in
ovaries and testis respectively, p,0.001, t-test). No detectable
variation in protein levels was observed in brain and cerebellum of
heterozygous mice. To ensure that the observed decrease of
MSH2 protein was not due to a decreased sensitivity/avidity of the
mutant MSH2 to the anti-MSH2 antibody, we also assessed the
levels of MSH3 and MSH6 proteins and found these to be
decreased in tissues of the Msh2 ATPase-mutant mice with a
pattern similar to the decrease of MSH2 (Figure 5).
To determine if the mutation decreases MSH2 expression at the
RNA level, we measured transcript levels in Msh2G674A/G674A and
wild-type tissues by qRT-PCR.Our analysis showed that the quantity
of Msh2G674A transcripts is unchanged in homozygous mutant mice
compared to wild-type mice (data not shown). Therefore, our results
suggest that the missense mutation in MSH2 ATPase domain
probably destabilizes MSH2 protein in adult mice.
Discussion
Since the discovery of dynamic mutations, which are responsible
for more than 20 neurological and/or neuromuscular diseases, many
studies have focused on understanding the molecular mechanism of
instability. Various data have clearly revealed that MSH2, MSH3,
MSH6 and PMS2 are required for CTGNCAG expansions in mouse
model systems [15–20]. However, the mode of action of these
proteins in the generation of trinucleotide expansions remains
unclear. It has been reported that MSH2-MSH3 ATPase activity
was reduced upon binding to CAG hairpins, this was interpreted as
Figure 1. Intergenerational instability of CTG repeat in Msh2G674A mutant and wild-type mice. The x-axis shows CTG repeat length
changes and the y-axis the percentage corresponding to each size changes for all transmissions analysed. Genotypes of parent and offspring are
indicated on the left of each graph. For male transmissions, the transmitting progenitors were aged 14–52 weeks and carried an expanded
trinucleotide sequence varying 395 to 563 CTG repeats. For female transmissions, the transmitting progenitors were aged 10–40.5 weeks and carried
an expanded trinucleotide sequence varying from 401 to 647 CTG repeats.
doi:10.1371/journal.pgen.1000482.g001
MSH2 ATPase Domain and Repeat Instability
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impairing the repair of the CAG hairpin permitting its integration as
an expansion [18]. In contrast, MutSb was not required for either
the correct or protected repair of slipped-CTGNCAG repeats,
suggesting that MutSb may be required to form these DNA
structures with an unknown involvement of ATP hydrolysis [33].
Nevertheless, the role of the MutL homologue PMS2 in the
Figure 2. Somatic mosaicism in 8-month-old Msh2+/+, Msh2G674A/+ and Msh2G674A/G674A transgenic males. bl, blood; p, pancreas; l, liver; t,
testis; s, sperm; h, heart; b, brain; c, cerebellum; q, quadriceps. M. 250 bp DNA ladder converted to number of CTG repeat units in the given PCR
product. Msh2 +/+/, m/+ and m/m represent genotypes at the murine locus for Msh2. +: wild-type allele; m: Msh2G674A mutation. The Msh2 +/+, m/+
and m/m males in tail extracted DNA at weaning contained 525, 516 and 500 CTG repeats, respectively.
doi:10.1371/journal.pgen.1000482.g002
Figure 3. Representative SP-PCR analyses of CTG repeats in DNA molecules extracted from 8-month-old transgenic mouse tissues.
The autoradiographs show representative SP-PCR analyses of DNA, extracted from ovaries and testis (A), brain and cerebellum (B). Genotypes are
indicated. CTG repeat numbers determined in tail DNA at weaning are: 535 (Msh2+/+); 512 (Msh2m/+); 499 (Msh2m/m) in mice used to analyse DNA from
ovaries and 525 (Msh2+/+); 516 (Msh2m/+); 500 (Msh2m/m) in the mice used for other tissues. t, tail; bl, blood; l, liver; M. 250 bp DNA ladder converted to
number of repeat units in the given PCR product. About 2–10 amplifiable DNA molecules (ovaries, brain and cerebellum) and 10–50 transgene
molecules (testis) were amplified. Msh2+/+, m/+ andm/m represent genotypes at the murine locus forMsh2. +: wild-type allele; m:Msh2G674A mutation.
doi:10.1371/journal.pgen.1000482.g003
MSH2 ATPase Domain and Repeat Instability
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formation of somatic expansions suggests that MMR pathway could
be involved in the mechanism of instability [17]. In our study, we
have shown that the G674A mutation in MSH2 ATPase domain
strongly affects the formation of intergenerational expansions.
Msh2G674A/G674A transgenic mice showed a strong bias towards
contractions compared to Msh2+/+ transgenic mice which showed a
strong bias towards expansions in their offspring. In the homozygous
Msh2G674A/G674A mice, we observed only 12.1% of expansions for
paternal transmissions and no expansions for maternal transmissions
(versus 100% and 62.3% in both male and female wild-type
transmissions, respectively). These results suggested that a functional
MSH2 ATPase domain is necessary to generate intergenerational
Figure 4. MSH2 protein levels in 3 to 4-month-old mice carrying different Msh2 genotypes. (A) Western blot analysis of MSH2 protein
levels in ovaries, testis, brain and cerebellum from Msh2+/+, Msh22/+, Msh22/2 (C57BL/6J, 129/OLA, FVB), Msh2+/+, Msh2m/+ and Msh2m/m (.90%
C57BL/6J) mice. b-actin was used as a loading control. Each lane represents pooled protein extracts from three mice. MSH2: 104 kDa and b-actin:
642kDa. (B) The graphs show the quantitative analysis of MSH2 protein expression levels relative to b-actin in the tested tissues. The quantification
has been performed by western blotting reproduced at least three times for each tissue. The x-axis shows MSH2/b-actin ratio. For each graph, all
values have been calculated considering the value of Msh2+/+ (C57BL/6J) as the reference value 1. **, p,0.005. +/+, m/+ and m/m represent
genotypes at the murine locus for Msh2. +: wild-type allele; m, Msh2G674A mutation. Error bars correspond to S.D.
doi:10.1371/journal.pgen.1000482.g004
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expansions. These results also suggest that the defective ATPase
domain is sufficient to yield a contraction bias similar to the Msh2-
null mice. In testis, where 89.3% of seminiferous tubules are
germinal cells [40], we observed a decrease of MSH2 levels of,50%
in theMsh2G674A/G674A mice. This coupled with the severe reduction
of expansions upon maleMsh2G674A/G674A transmissions (from 100%
for Msh2+/+ down to 12% for the mutant mice) compared to the
negligible effect forMsh22/+mice (92%, Table S1 and [19]) strongly
argue that a functional ATPase activity is required for expansions.
Then, the deficiency of the ATPase domain in conjunction with
decreased protein levels are responsible for the decrease of expansion
frequency. Furthermore, it demonstrates that the apoptosis signaling
function of MSH2, described to be non affected by the G674A
mutation [34], is not involved in the mechanism generating CTG
repeat expansions.
We also observed that the G674A mutation of one Msh2 allele
was sufficient to decrease the frequency of expansions in both male
and female transmissions (from 100% to 75% expansions and from
62.3% to 37.9% for male and female transmissions, respectively).
Such a decrease in the frequency of expansions was not observed
for male transmissions in heterozygous Msh22/+ mice which
displayed 92% expansions similar to Msh2+/+ mice; indicating that
in this context a single functional Msh2 allele was sufficient to drive
the same level of expansions as two functional alleles [19]. In
contrast, our results show that a functional MSH2 protein in the
presence of an ATPase mutant MSH2G674A protein was not
sufficient to drive the same levels of expansions; but yielded
reduced expansion levels for paternal and maternal transmissions
– further supporting a requirement of the ATPase domain. To this
degree our data suggest that the MSH2G674A mutant protein could
act as a dominant-negative mutant, effectively blocking the ability
of the wild-type MSH2 protein from driving CTGNCAG
expansions. This purported dominant negative function would
be specific to CTGNCAG expansions, as a dominant-negative
mutator effect was not observed for either mono- or dinucleotide
microsatellites in the heterozygous Msh2G674A/+ mice [34]. In
concordance with our observed CTGNCAG effect, the S. cerevisiae
yMsh2 protein with the G693A (equivalent to the mammalian
G674A mutation) or G693D mutated ATPase domains cause a
dominant mutator phenotype [41,42]. The mutant yMsh2G693A-
yMsh6 complex binds to DNA mismatches and is not released in
the presence of ATP. This could block access of wild-type proteins
and subsequently inhibit normal repair [43]. In the case of
CTGNCAG repeats, the MSH2G674A mutant protein could
partially block the access of the wild-type MSH2-MSH3 complex
to unpaired CAG repeats, therefore protecting it from being
processed to expansions. There is no data concerning the ability of
the MSH2G674A-MSH3 complex to bind trinucleotide repeats.
The analogous mutation in the conserved Walker domain of the
prokaryote MutS protein (K620M) results in a weak mismatch
Figure 5. MSH2, MSH3 and MSH6 protein levels in 3 to 4-month-old mice carrying different Msh2 genotypes. Western blot analysis of
MSH2, MSH3 and MSH6 protein levels in ovaries, testis, brain and cerebellum from Msh2+/+, Msh22/+, Msh22/2 (C57BL/6J, 129/OLA, FVB), Msh2+/+,
Msh2m/+ and Msh2m/m (.90% C57BL/6J) mice. b-actin was used as a loading control. Each lane represents pooled protein extracts from three mice.
MSH2: 104 kDa, MSH3: 123 kDa, MSH6: 160kDa and b-actin: 642kDa.
doi:10.1371/journal.pgen.1000482.g005
MSH2 ATPase Domain and Repeat Instability
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binding activity and in a decrease in ATP binding and hydrolysis
[24,44]. However, in the case of MutS homoduplex in bacteria,
both subunits of the complex are affected by the mutation. In
eukaryotes, MSH2 partners (MSH3 or MSH6) retain their
capacity to bind and hydrolyse ATP and it has been shown that
MSH6 binds ATP with higher affinity and hydrolyses ATP faster
than MSH2 [45]. Mispair binding is regulated by mismatch-
stimulated ADP to ATP exchange inducing conformational
changes to the N-terminus mispair binding domain [24,46].
Recent data have shown that human MutSa and MutSb have
different ADP binding and ATPase activities in vitro that could
explain the preferential processing of base-base and insertion/
deletion mispairs by these two complexes [25]. In the mice used in
this study, the MSH2G674A-MSH6 complex is able to bind to
mismatches but the ATP-mediated disassociation from the
substrate containing a G/T mismatch is reduced [34]. It is not
known if the binding of MSH2G674A-MSH3 is affected by the
mutation. However, the possible dominant-negative function of
MSH2G674A on CTGNCAG expansions suggest that MSH2G674A-
MSH3 may still be able to bind to trinucleotide repeat expansions.
In Msh2G674A/G674A mice, we observed a dramatic decrease of
somatic CTG expansions together with a decrease of MSH2
protein levels in adult somatic tissues, such as brain and
cerebellum. Because the stability of MSH2, MSH3 and MSH6
depends on the ability of these proteins to form heterodimers, the
levels of MSH3 and MSH6 were also found decreased in mutant
tissues. However, MSH3 and MSH6 were clearly detected in
homozygous mutant mice showing that the mutant MSH2G674A
protein was still able to form the MutSb and MutSa complexes.
While this reduction varied between tissues, a role of the ATPase
domain in somatic instability seemed to be implicated. The
dramatic loss of CTG instability in Msh2G674A/G674A mouse brains,
which show as much as 62% of MSH2 protein strongly suggests
that a functional ATPase domain is required for the formation of
somatic expansions. The decrease of protein levels in the germinal
and somatic tissues of Msh2G674A/G674A mice was unexpected as no
decrease was observed in MEF cells from these mice [34].
Furthermore, Ollila et al recently observed that the production of
human recombinant MSH2G674A-MSH6 complex was expressed
in amount similar to the wild-type hMutSa suggesting that the
G674A mutation did not affect protein stability [47]. However, a
lowered interaction of MSH2G674A with MSH6 was reported in
this study. Interestingly, the difference in hMutSa expression levels
between various cell lines was shown to result from cell-dependent
differences in the degradation rate of both proteins forming the
complex, by the ubiquitin-proteasome pathway [48]. Further-
more, the protein kinase PKCf is able to phosphorylate hMutSa
and regulates MSH2 and MSH6 protein stability and levels by
inhibiting the ubiquitin-proteasome dependent degradation of
these proteins [49]. It is unknown if the stability of MSH3 is
regulated by the same pathway but the regulation of MSH2
stability has a direct impact on the regulation of MutSb. It is
possible that the Msh2G674A mutation affects the sensitivity of
MSH2 to the ubiquitin-proteasome degradation pathways possibly
by altering its ability to be phosphorylated. In this manner a tissue-
specificity in the efficiency of the ubiquitin-proteasome degrada-
tion pathways would account for the different decrease of
MSH2G674A protein that we observed in the various mouse
tissues. Interestingly, we found a putative PKC phosphorylation
site at threonine 677; proximal to the G674A mutation, in the
human and mouse MSH2 proteins using the NetPhosK 1.0 server
(output score 0.89 using the Evolutionary Stable Sites filter) [50].
While tissue-specific regulation of MSH2 protein levels is beyond
the scope of the present study, it is clear that the altered CTG
instability we observe with the Msh2G674A mutation indicates that
an ATPase-competent MSH2 protein is necessary to drive
CTGNCAG expansions and that in its absence contractions
predominate in parent-to-offspring transmissions.
It is noteworthy, that the levels of CTGNCAG contractions in
either Msh2G674A/G674A, or Msh3-null mice is considerably greater
in parent-offspring transmissions than in their somatic tissues ([20]
and this study). The formation of high levels of contractions of
expanded CTGNCAG repeats transmitted from parent-to-offspring
depends upon the homozygous loss of Msh2 or Msh3, or a
homozygous Msh2 G674A/G674A mutation, and occur to some
degree in a heterozygous Msh2G674A/+ mutant. One interpretation
is that the contractions would normally have been prevented by
the presence of MSH3 and MSH2 with a functional ATPase
domain. It would be of interest to learn if the germline-specific
MSH2–MSH3:MLH3-MLH1/PMS2 complexes, detected at
centromeric and Y chromosome repeats and proposed to prevent
deleterious crossover events at repetitive DNAs [28], also form at
expanded CTGNCAG transgenes in germ cells of transgenic mice.
They may be linked to transmitted repeat contractions.
In conclusion, our finding that a functional MSH2 ATPase
domain is required for CTGNCAG expansion mutations makes this
the third mutagenic process for which its activity is required. The
ATPase activity of MSH2 has been previously demonstrated to be
required for both somatic hypermutation and class switch recombi-
nation at immunoglobin genes [26,27]. Our data demonstrate that
the Msh2G674A mutation affects CTGNCAG repeat instability in
transgenic mice and almost completely abolishes the formation of
intergenerational and somatic expansions and leads to a high level of
contractions in parental transmissions. The G674A mutation also
decreases the levels of MSH2 protein in a tissue-specific manner. The
decrease of MSH2 protein cannot account totally for the dramatic
decrease of expansions. Therefore, CTGNCAG repeat expansions are
likely affected by cumulative effects of its defective ATPase domain
and reduced MSH2 protein levels. If we assume that the binding of
MSH2G674A-MSH3 is not affected by the mutation, our data would
suggest that the binding of MutS complexes to the trinucleotide
repeats is not sufficient to drive instability towards expansion and that
a fully functional MSH2 ATPase domain is required. This does not
support the hypothesis that a decrease of ATP hydrolysis by MSH2-
MSH3 bound to trinucleotide repeats and aborted repair of DNA
hairpin loops could cause expansions. On the contrary, our data
sustain the hypothesis according to which a functional MMR activity
is required to generate expansions.
Materials and Methods
Mouse Breeding and Genotyping
DM300-328 transgenic mice (.90% C57BL/6 background)
carrying very large human genomic sequences (45 kb) and .300
CTG repeats [36] were crossed over successive generations with
Msh2G674A mutant mice [27,34]. Genotype was determined by
PCR on 25 ng of DNA extracted from tail at weaning. Transgenic
status of mice was performed with 0.5 mM of oligonucleotide
primers HS3 (59-TGAAGATGAAGCAGACGGG-39) and HS4
(59-TCCCCATTCACCAACAC-39), 16ReddyMix PCR Master
Mix (Thermo Scientific). The DNA was denatured by heating to
94u for 6 min. Reactions involved 30 cycles of 94uC (30 s), 55uC
(30 s) and 72uC (30 s) with a chase of 10 min at 72uC. Msh2
genotype was determined with 0.35 mM of oligonucleotide
primers in12/13 (59-GTGGGTTTGTCTGACTGAATG-39)
and ex13/3 (59 -GGATGGAAGAAGTCTCCAGC-39), 16Red-
dyMix PCR Master Mix and 2.5 mM of MgCl2. After initial
denaturation for 10 min at 94uC, reactions were performed for
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30 s at 94uC, 30 s at 60uC and 45 s at 72uC for 35 cycles followed
by a chase of 7 min at 72uC. The sizes of predicted PCR products
were 596 and 411 bp for mutant and wild-type alleles, respectively.
Msh22/+ (129/OLA, FVB background) mutant mice and
genotype by multiplex PCR have been described by de Wind et
al. [51]. Housing and handling of mice were performed according
to French government ethical guidelines.
CTG Repeat Analysis
Intergenerational instability was investigated by comparison of
the CTG repeat lengths in transgenic parent and offspring. DNA
was extracted from tail collected at weaning by isopropanol
precipitation. To determine the CTG repeat length in transgenic
mice, 15 ng of tail DNA samples were amplified in 25 ml reaction
using 0.4 mM 101 and 102 primers [36], 16Custom master mix
(Thermo Scientific) and 0.04U Thermoperfect Taq polymerase
(Integro BV). The following cycling conditions were used: 5 min at
96uC; 45 s at 96uC, 30 s at 68uC and 3 min at 72uC (30 cycles);
1 min at 68uC and 10 min at 72uC (1 cycle). Electrophoresis of
PCR products was performed using a previously described method
[52]. The amplified product (from 2 ml to 5 ml) was mixed with
DNA-loading dye and subjected to electrophoresis in 0.7–0.8%
agarose gels at 300 V for 30 min and then 160 V overnight at 4uC.
After electrophoresis, the gel was incubated in depurinating solution
(0.25 M HCl) for 10 min, denaturing solution (0.5 M NaOH,
1.5 M NaCl) for 30 min and neutralization solution (1.5 M NaCl,
0.5 M Tris-HCl, pH 7.5) for 30 min. DNA was blotted onto
positive nylon membrane (MP Biomedicals), UV-crosslinked (UV
Stratalinker 2400, Stratagene) and hybridised with a double-strand
CTG DNA probe radiolabelled with a-32P-dCTP using Amersham
ready-to-goTM DNA labelling beads (-dCTG) (GE Healthcare).
CTG repeat lengths were compared with a 250 bp DNA ladder
loaded on the same gel and analysed by Quantity One-1-D Analysis
Software (Bio-Rad Laboratories). Somatic instability was analysed
in various tissues collected from 8-month-old mice. DNA was
phenol/chloroform-extracted from tissues [14] and sperm DNA
was extracted according to Seznec et al. [36]. CTG repeat instability
was determined as described above.
Small-Pool PCR (SP-PCR) Analysis
DNA extraction, SP-PCR amplifications and PCR product
electrophoretic analyses were performed using the methods
previously described [52]. DNA samples were digested with
HindIII and SP-PCR was performed with DM-C and DM-BR
primers [52]. SP-PCR products from mice with different Msh2
genotypes and tail/blood or tail/liver PCR products were loaded
on the same 0.7% agarose gel to compare instability between
Msh2+/+, Msh2G674A/+ and Msh2G674A/G674A mice.
Protein Sample Preparation and Western Blotting
The different tissues were collected from 3 to 4-month-old-mice
with different Msh2 genotypes and pooled for protein extraction
(three mice for each genotype). Proteins were extracted by
mechanical homogenisation in lysis buffer (0.125 M Tris-HCl
pH 6.8, 4% SDS, 10% glycerol) containing complete Mini 76
protease inhibitor cocktail (Roche) and 1 mM PMSF (Sigma).
Protein concentration was determined using the Bio-Rad protein
assay . 20 mg of proteins were denatured 5 min at 95uC in Laemmli
sample buffer (Bio-Rad) supplemented with 5% b-mercaptoethanol
added extemporaneously, resolved by electrophoresis on a 10%
polyacrylamide SDS-PAGE gel and electroblotted onto Millipore
Immobilon-P membranes (Millipore) in tranfer buffer (25 mMTris-
HCl pH 8.0, 192 mM glycine, 20% methanol and 0.1% SDS) at
350 mA at 4uC for 1h30. Membranes were blocked for one hour at
room temperature in 5% blotto in TBST pH 7.5 ( 10 mM Tris-
HCl, 0.15 mM NaCl and 0.05% Tween 20), then incubated
overnight at 4uC in primary antibody. The membranes were
washed once for 5 min, 10 min and 15 min each in TBST,
incubated for 1h in secondary antibody (Jackson Immuno-research,
sheep anti-mouse-HRP, 1:5000) at room temperature for MSH2,
MSH3, MSH6 and for actin, and washed one time for 5 min,
10 min and 15 min each in TBST. Antibody binding was visualized
using ECLTM Western blotting analysis system and ECL plus
Western blotting detection system (Amersham).MSH2,MSH6, and
actin were detected using antibodies mouse anti-MSH2 (Oncogene,
Ab-2, 1:200), mouse anti-MSH6 (BD Laboratories, 1:500), and
mouse monoclonal b-actin (gift from Dr Manuel Herna`ndez,
1:400). The MSH3 monoclonal antibody was raised against an N-
terminal fragment of mouse MSH3 (amino acids 24 to 308 of NCBI
sequence NP_034959) and its specificity was confirmed using
Msh3+/+ and Msh32/2 mouse tissues (dilution 1:500).
Western blotting was reproduced at least three times for each
tissue to make semi-quantitative analysis. Densitometric analysis of
protein levels was performed using Quantity One-1-D Analysis
Software (Bio-Rad Laboratories) using non-saturated exposures.
Statistical Analysis
Statistical analyses for instability distributions were performed
with StatView software using the Mann-Whitney test (SAS
Institute Inc.). The statistical analysis of the levels of MSH2
protein was performed with StatView software using t-test. The
detected differences in total transmissions and in MSH2 protein
levels were considered statistically significant only if p,0.05.
Supporting Information
Table S1 Intergenerational CTG repeat instability in knockout
Msh2 mice.
Found at: doi:10.1371/journal.pgen.1000482.s001 (0.03 MB
DOC)
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